# Association of lipoprotein(a), oxidized phospholipids and apolipoprotein B100 in acute ischemic stroke cohort

**Authors:** Yihao Li, Emmie Then, Salwa Rahman, Nelsa Matienzo, Anastasiya Matveyenko, Marianna Pavlyha, Farid Khasiyev, Randolph S Marshall, Joshua Willey, Jose Gutierrez, Gissette Reyes-Soffer

PMC · DOI: 10.70401/alr.2026.0005 · Advances in lipoprotein(a) research · 2026-02-26

## TL;DR

This study explores how lipoprotein(a) and related biomarkers are linked to atherosclerotic stroke subtypes, finding associations with specific stroke types.

## Contribution

The study identifies specific Lp(a)-related biomarkers associated with atherosclerotic stroke subtypes, particularly extracranial atherosclerotic disease.

## Key findings

- High Lp(a) concentrations are linked to atherosclerotic stroke compared to non-atherosclerotic strokes.
- Oxidized phospholipids on APO(a) are associated with atherosclerotic stroke subtypes.
- These biomarkers are specifically tied to extracranial atherosclerotic disease.

## Abstract

Atherosclerosis, affecting the aorta, cervical, or intracranial arteries, is a common cause of stroke. Previous studies have shown a strong link between high Lp(a) levels and atherosclerotic stroke due to intracranial atherosclerotic disease, implicating Lp(a) in disease development and progression. The precise role of Lp(a) in stroke subtypes remains unclear, although smaller isoform sizes and oxidized phospholipids on Lp(a) are associated with the disease presence. To clarify Lp(a)’s connection with ischemic stroke subtypes, we evaluated various plasma biomarkers previously linked to Lp(a) and disease.

We used stored plasma samples and data from 244 participants enrolled in an acute ischemic stroke registry at Columbia University Medical Center in New York. Plasma Lp(a) concentrations, apolipoprotein B100 (APOB), and oxidized phospholipids were measured via enzyme-linked immunosorbent assay. APO(a) isoform size was measured via gel electrophoresis. Stroke subtypes were classified based on etiologies using clinical and imaging data. Adjusted multivariate logistic regression models were built to assess associations between Lp(a)-related biomarkers and stroke subtype.

In participants with acute ischemic stroke, high Lp(a) concentrations, percentage of APOB in Lp(a), and OxPL-APO(a) concentrations were significantly associated with the presence of atherosclerotic stroke compared to those with non-atherosclerotic strokes [OR = 1.30 (p = 5.7e - 3), 1.29 (p = 6.9e - 3), 1.27 (p = 1.7e - 2), respectively]. In participants with atherosclerotic stroke, these changes were significantly associated with extracranial atherosclerotic stroke (ECAD), with an OR = 0.69, p = 4e - 2.

In addition to Lp(a) concentrations, the percentage of APOB in Lp(a), and OxPL-APO(a) concentrations are positively associated with acute atherosclerotic ischemic stroke, specifically ECAD.

## Linked entities

- **Proteins:** APOB (apolipoprotein B), APOA1 (apolipoprotein A1)
- **Diseases:** stroke (MONDO:0005098), atherosclerosis (MONDO:0005311)

## Full-text entities

- **Genes:** APOB (apolipoprotein B) [NCBI Gene 338] {aka FCHL2, FLDB, LDLCQ4, apoB-100, apoB-48}, LPA (lipoprotein(a)) [NCBI Gene 4018] {aka AK38, APOA, LP}, AOPEP (aminopeptidase O (putative)) [NCBI Gene 84909] {aka AP-O, APO, C90RF3, C9orf3, DYT31, ONPEP}
- **Diseases:** artery strokes (MESH:D020243), hypercholesterolemia (MESH:D006937), transient ischemic attack (MESH:D002546), coronary atherosclerosis (MESH:D003324), ischemic stroke (MESH:D002544), cardiovascular disease (MESH:D002318), OxPL (MESH:D016736), vascular injury (MESH:D057772), Atherosclerotic (MESH:D050197), hypertension (MESH:D006973), death (MESH:D003643), AIS (MESH:D000083242), small vessel stroke (MESH:D059345), Acute Stroke (MESH:D020521), atherosclerotic ischemic stroke (MESH:D002537), ischemic (MESH:D002545), Diabetes (MESH:D003920), hemorrhagic stroke (MESH:D000083302), large artery disease (MESH:D002539), inflammation (MESH:D007249), coronary heart disease (MESH:D003327)
- **Chemicals:** a (MESH:D001151), phosphocholine (MESH:D010767), glucose (MESH:D005947), agarose (MESH:D012685), Lipid (MESH:D008055), Lp(a) (MESH:D010649), ECAD (-), TG (MESH:D013866), OxPL (MESH:C017607), Cholesterol (MESH:D002784), Org 10172 (MESH:C035838), phospholipid (MESH:D010743), EDTA (MESH:D004492), C (MESH:D002244), triglyceride (MESH:D014280), saline (MESH:D012965)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12933386/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12933386/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12933386/full.md

---
Source: https://tomesphere.com/paper/PMC12933386